Publication | Closed Access

Prasugrel overcomes high on-clopidogrel platelet reactivity in chronic coronary artery disease patients more effectively than high dose (150 mg) clopidogrel

ThrombopoiesisThrombosisCardiovascular DiseaseHigh DoseMedicineBlood PlateletPharmacotherapyPlatelet AntagonistPharmacologyAnticoagulantCardiologyCoronary Artery Disease